Oxford Index Browse

You are looking at 1-20 of 56,706 items for:

Medical Oncology x clear all

Refine by subject

 

Refine by type

Refine by product

 

A “PRECISION MEDICINE” STRATEGY FOR RECURRENT GLIOBLASTOMA

Michael Prados.

in Neuro-Oncology

July 2014; p ublished online July 2014 .

Journal Article. Subjects: Medical Oncology; Neurology. 0 words.

BACKGROUND: Despite years of intense clinical research and clinical trials, there are essentially no effective therapies proven to increase survival at the time of tumor progression in...

A ‘one stop cancer screening shop’, a way of improving screening participation rates?

A. Bobridge, K. Price and A. Taylor.

in Annals of Oncology

October 2016; p ublished online October 2016 .

Journal Article. Subjects: Medical Oncology. 357 words.

A ‘shock and awe’ thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium–intracellulare complex disease

Shashikant Srivastava, Devyani Deshpande, Carleton M. Sherman and Tawanda Gumbo.

in Journal of Antimicrobial Chemotherapy

September 2017; p ublished online September 2017 .

Journal Article. Subjects: Medical Oncology; Critical Care. 3246 words.

Abstract

Objectives

To develop a thioridazine/moxifloxacin-based combination regimen for treatment of pulmonary...

A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital

Fabien Garnier, Delphine Chainier, Timothy Walsh, Asa Karlsson, Anne Bolmström, Carole Grelaud, Marcelle Mounier, François Denis and Marie-Cécile Ploy.

in Journal of Antimicrobial Chemotherapy

January 2006; p ublished online November 2005 .

Journal Article. Subjects: Medical Oncology; Critical Care. 1969 words.

Objectives: Glycopeptides are the drugs of choice to treat infections due to methicillin-resistant Staphylococcus aureus, but since 1995, glycopeptide-intermediate S. aureus (GI...

Go to »  abstract

A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital

Fabien Garnier, Delphine Chainier, Timothy Walsh, Asa Karlsson, Anne Bolmström, Carole Grelaud, Marcelle Mounier, François Denis and Marie-Cécile Ploy.

in Journal of Antimicrobial Chemotherapy

March 2006; p ublished online January 2006 .

Journal Article. Subjects: Medical Oncology; Critical Care. 101 words.

Go to »  abstract

A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project.

T G Winstanley, D I Limb, R Eggington and F Hancock.

in Journal of Antimicrobial Chemotherapy

October 1997; p ublished online October 1997 .

Journal Article. Subjects: Medical Oncology; Critical Care. 0 words.

Microbe Base is a national computerized database comprising in excess of 1.7 million patient records down-loaded from the laboratory computer systems of 61 participating UK laboratories...

Go to »  abstract

A 10-year Follow-up of Triple-negative Breast Cancer Patients in Taiwan

Che Lin, Su-Yu Chien, Shou-Jen Kuo, Li-Sheng Chen, Shou-Tung Chen, Hung-Wen Lai, Tsai-Wang Chang and Dar-Ren Chen.

in Japanese Journal of Clinical Oncology

March 2012; p ublished online January 2012 .

Journal Article. Subjects: Medical Oncology. 3407 words.

Objective

This study aimed to investigate whether triple-negative breast cancer has a worse prognosis; here, we present the 10-year follow-up results of...

Go to »  abstract

A 12 year (1998–2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals

C. F. M. van der Donk, P. S. Beisser, J. A. A. Hoogkamp-Korstanje, C. A. Bruggeman and E. E. Stobberingh.

in Journal of Antimicrobial Chemotherapy

April 2011; p ublished online January 2011 .

Journal Article. Subjects: Medical Oncology; Critical Care. 2067 words.

Objectives

We evaluated the changes in antibiotic resistance from 1998 to 2009 of Klebsiella pneumoniae isolated from the intensive care units (ICUs) and...

Go to »  abstract

A 12-mer repetitive antigenic epitope from Trypanosoma cruzi is a potential marker of therapeutic efficacy in chronic Chagas' disease

Ana Fernandez-Villegas, M. Carmen Thomas, Bartolomé Carrilero, Paola Lasso, Adriana Egui, Laura Murcia, Manuel Segovia, Carlos Alonso and Manuel Carlos López.

in Journal of Antimicrobial Chemotherapy

July 2016; p ublished online April 2016 .

Journal Article. Subjects: Medical Oncology; Critical Care. 2575 words.

Objectives

The objective was to characterize a Trypanosoma cruzi repetitive amino acid sequence that can be used as a marker of therapeutic drug efficacy in...

A 12-mm Carcinoid Tumor of the Minor Duodenal Papilla with Lymph Node Metastases

Yasuyuki Fukami, Yasuhiro Kurumiya, Keisuke Mizuno, Ei Sekoguchi, Satoshi Kobayashi, Akira Ito, Akihiro Tomida, Sakura Onishi, Ryo Shirotsuki, Kenji Okubo and Michihiko Narita.

in Japanese Journal of Clinical Oncology

January 2013; p ublished online November 2012 .

Journal Article. Subjects: Medical Oncology. 1373 words.

Carcinoid tumors located in the minor duodenal papilla are extremely rare, with only a few cases reported in the literature. Herein, we report the case of a 71-year-old man with a 12-mm...

Go to »  abstract

A 12-week regimen with interdigitating FOLFOX/bevacizumab and pelvic chemoradiation for synchronous primary and metastatic rectal cancer. The CHROME B trial

S. Ngan, M. Bressel, J. Chu, J. McKendrick, S. Chander, P. Cooray, M. Jefford, R. Wong, M. Steel, T. Leong, A. Heriot and M. Michael.

in Annals of Oncology

October 2016; p ublished online October 2016 .

Journal Article. Subjects: Medical Oncology. 384 words.

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial

K. Fizazi, K.-A. Do, X. Wang, L. Finn, C. J. Logothetis and R. J. Amato.

in Annals of Oncology

January 2002; p ublished online January 2002 .

Journal Article. Subjects: Medical Oncology. 5789 words.

Background: This prospective randomized clinical trial was designed to compare the efficacy of a low-dose regimen of cisplatin, doxorubicin and cyclophosphamide alternated with...

Go to »  abstract

A 25-Signal Proteomic Signature and Outcome for Patients With Resected Non–Small-Cell Lung Cancer

Kiyoshi Yanagisawa, Shuta Tomida, Yukako Shimada, Yasushi Yatabe, Tetsuya Mitsudomi and Takashi Takahashi.

in JNCI: Journal of the National Cancer Institute

June 2007; p ublished online June 2007 .

Journal Article. Subjects: Medical Oncology. 7367 words.

Background

Among patients with non–small-cell lung cancer (NSCLC), those with poor prognosis cannot be distinguished from those with good prognosis.

null...

A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study

G. Frasci, G. D'Aiuto, P. Comella, R. Thomas, G. Botti, M. Di Bonito, M. D'Aiuto, G. Romano, M. R. Rubulotta and G. Comella.

in Annals of Oncology

August 2005; p ublished online June 2005 .

Journal Article. Subjects: Medical Oncology. 5482 words.

Purpose: The present study aimed to define the antitumor activity of eight cisplatin–epirubicin–paclitaxel (PET) weekly cycles with granulocyte colony-stimulating factor (G-CSF)...

Go to »  abstract

A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette–Guérin is Safe, Adherent and Effective in Patients with Non-muscle-invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial

in Japanese Journal of Clinical Oncology

September 2012; p ublished online July 2012 .

Journal Article. Subjects: Medical Oncology. 3839 words.

Objective

To investigate the safety and efficacy of a maintenance regimen of bacillus Calmette–Guérin therapy including 6-week induction and 2-week...

Go to »  abstract

A 3 year survey on the use of antibacterial agents in five Italian hospitals

Alberto Vaccheri, Maria Chiara Silvani, Laura Bersaglia, Domenico Motola, Petar Strahinja, Antonio Vargiu, Elisabetta Poluzzi and Nicola Montanaro.

in Journal of Antimicrobial Chemotherapy

April 2008; p ublished online January 2008 .

Journal Article. Subjects: Medical Oncology; Critical Care. 2887 words.

Background

Misuse of antimicrobial agents in hospitals may cause the emergence of resistant microorganisms, as well as increased costs and unnecessary...

Go to »  abstract

A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

in Annals of Oncology

May 2015; p ublished online April 2015 .

Journal Article. Subjects: Medical Oncology. 149 words.

Go to »  abstract

A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

C. H. Chung, J. W. Lee, R. J. Slebos, J. D. Howard, J. Perez, H. Kang, E. J. Fertig, M. Considine, J. Gilbert, B. A. Murphy, S. Nallur, T. Paranjape, R. C. Jordan, J. Garcia, B. Burtness, A. A. Forastiere and J. B. Weidhaas.

in Annals of Oncology

November 2014; p ublished online July 2014 .

Journal Article. Subjects: Medical Oncology. 3440 words.

Background

A germline mutation in the 3′-untranslated region of KRAS (rs61764370, KRAS-variant: TG/GG) has previously been associated with altered patient...

Go to »  abstract

A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma

G. Kobbe, I. Bruns, T. Schroeder, A. Czibere, J. Warnecke, N. Hieronimus, N. Safaian, M. Kondakci, C. Saure, U. Germing, R. Haas and R. Fenk.

in Annals of Oncology

September 2010; p ublished online March 2010 .

Journal Article. Subjects: Medical Oncology. 4293 words.

Background: We retrospectively determined whether a 3-day short course of palifermin could reduce the toxicity of high-dose therapy (HDT) and autologous blood stem-cell...

Go to »  abstract

A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells

Katharina Hansen, Franz-Josef Müller, Markus Messing, Frank Zeigler, Jeanne F. Loring, Katrin Lamszus, Manfred Westphal and Nils Ole Schmidt.

in Neuro-Oncology

July 2010; p ublished online February 2010 .

Journal Article. Subjects: Medical Oncology; Neurology. 5088 words.

Neural stem/progenitor cells (NSPCs) display inherent pathotropic properties that can be exploited for targeted delivery of therapeutic genes to invasive malignancies in the central nervous...

Go to »  abstract